Tamoxifen induced non-purpuric cutaneous leukocytoclastic vasculitis

Breast J. 2019 Mar;25(2):320-321. doi: 10.1111/tbj.13218. Epub 2019 Feb 12.

Authors

Kurian Joseph¹, Muba Taher², Gilbert Bigras³, Karen King¹

Affiliations

¹ Department of Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada.
² Division of Dermatology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
³ Department of Laboratory Medicine & Pathology, University of Alberta, and Cross Cancer Institute, Edmonton, Alberta, Canada.

PMID: 30746834
DOI: 10.1111/tbj.13218

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents, Hormonal / adverse effects*
Breast Neoplasms / therapy*
Female
Humans
Tamoxifen / adverse effects*
Vasculitis, Leukocytoclastic, Cutaneous / chemically induced*
Vasculitis, Leukocytoclastic, Cutaneous / pathology

Substances

Antineoplastic Agents, Hormonal
Tamoxifen